Alpha-fetoprotein (158-166)

Alpha-fetoprotein (158-166) is a synthetic peptide fragment derived from the amino acid sequence spanning residues 158 to 166 of the human alpha-fetoprotein (AFP) protein. As a functional peptide, it represents a specific epitope region within AFP, a well-characterized oncofetal glycoprotein involved in embryonic development and frequently studied as a biomarker in oncology and developmental biology. The 158-166 segment has garnered research interest due to its defined sequence, potential immunological relevance, and utility in probing AFP's biological roles. Its defined structure and sequence specificity make it an important tool for scientists investigating protein interactions, antigenicity, and peptide-mediated signaling pathways.

Epitope mapping: Researchers frequently employ the 158-166 peptide fragment for detailed epitope mapping studies of alpha-fetoprotein. By using this defined sequence, scientists can identify and characterize antibody binding sites, facilitating the development of highly specific immunoassays. Such mapping supports the generation of monoclonal antibodies targeting AFP, enabling precise detection and quantification in various immunological assays and advancing the understanding of antigen-antibody interactions at the molecular level.

Immunological assay development: The peptide serves as a valuable reagent for the optimization and validation of immunoassays, such as enzyme-linked immunosorbent assays (ELISA) and Western blotting protocols. Its well-defined sequence allows for the creation of synthetic standards or positive controls, ensuring assay specificity and sensitivity when detecting AFP or related immune responses. This application is critical for researchers developing diagnostic tools or monitoring experimental outcomes in cancer biology and developmental studies.

T-cell response investigations: Alpha-fetoprotein (158-166) is widely utilized in immunology research to assess T-cell epitope recognition and cellular immune responses. The peptide can be used to stimulate peripheral blood mononuclear cells or isolated T-cell populations, enabling the study of antigen-specific activation, cytokine production, and cytotoxic activity. Such investigations are fundamental for elucidating the mechanisms of immune surveillance and tolerance related to AFP-expressing cells, particularly in the context of tumor immunology and fetal-maternal interactions.

Peptide-protein interaction studies: The 158-166 sequence provides a model system for examining peptide-protein interactions, including binding affinities and structural conformations. By employing this fragment in binding assays, surface plasmon resonance, or co-immunoprecipitation experiments, researchers can dissect the molecular determinants of AFP's interactions with cellular receptors or other biomolecules. Insights gained from these studies contribute to the broader understanding of AFP's physiological and pathological functions.

Peptide synthesis and modification research: The defined nature of the alpha-fetoprotein (158-166) peptide makes it an ideal substrate for studies in peptide synthesis, structural modification, and conjugation chemistry. Synthetic chemists and biochemists can use this fragment to evaluate novel coupling strategies, labeling techniques, or peptide stabilization methods. Such work supports advancements in peptide-based reagent development, therapeutic research tools, and the creation of custom peptide libraries for high-throughput screening or structure-activity relationship analysis.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. Cationic cell-penetrating peptides are potent furin inhibitors

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function